Health Catalyst Inc [HCAT] stock is trading at $4.05, up 7.43%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HCAT shares have gain 8.14% over the last week, with a monthly amount glided 6.58%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Health Catalyst Inc [NASDAQ: HCAT] stock has seen the most recent analyst activity on June 17, 2025, when BTIG Research downgraded its rating to a Neutral. Previously, Evercore ISI downgraded its rating to In-line on April 09, 2025. On January 08, 2025, upgrade upgraded it’s rating to Overweight but maintained its price target of $9 on the stock. KeyBanc Capital Markets downgraded its rating to a Sector Weight. Evercore ISI upgraded its rating to a Outperform but $11 remained the price target by the analyst firm on January 03, 2024. Barclays started tracking with a Overweight rating for this stock on January 03, 2024, and assigned it a price target of $14. In a note dated December 13, 2023, JP Morgan upgraded an Overweight rating on this stock and revised its target price from $14 to $11.
Health Catalyst Inc [HCAT] stock has fluctuated between $3.49 and $9.24 over the past year. Currently, Wall Street analysts expect the stock to reach $5.67 within the next 12 months. Health Catalyst Inc [NASDAQ: HCAT] shares were valued at $4.05 at the most recent close of the market. An investor can expect a potential return of 40.0% based on the average HCAT price forecast.
Analyzing the HCAT fundamentals
Health Catalyst Inc [NASDAQ:HCAT] reported sales of 311.27M for the trailing twelve months, which represents a growth of 6.28%. Gross Profit Margin for this corporation currently stands at 0.42% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.23%, and Net Profit Margin reading is -0.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.2 and Total Capital is -0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.67.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.81 points at the first support level, and at 3.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.21, and for the 2nd resistance point, it is at 4.36.
Ratios To Look Out For
For context, Health Catalyst Inc’s Current Ratio is 1.24. As well, the Quick Ratio is 1.24, while the Cash Ratio is 1.01. Considering the valuation of this stock, the price to sales ratio is 0.91, the price to book ratio is 0.75.
Transactions by insiders
Recent insider trading involved Landry Benjamin, General Counsel, that happened on Jun 05 ’25 when 6057.0 shares were sold. Officer, BENJAMIN LANDRY completed a deal on Jun 05 ’25 to buy 6057.0 shares. Meanwhile, Officer Benjamin Landry bought 3255.0 shares on Jun 02 ’25.
